期刊文献+

人乳头瘤病毒中和抗体检测方法的研究进展 被引量:3

下载PDF
导出
摘要 人乳头瘤病毒疫苗已成为预防宫颈癌的最根本手段,而疫苗成功的关键是诱导有效的体液免疫,产生具有保护作用的中和抗体。本文就目前几种中和试验方法的原理及其优缺点进行综述。
出处 《中国生物制品学杂志》 CAS CSCD 2008年第7期632-636,640,共6页 Chinese Journal of Biologicals
  • 相关文献

参考文献3

二级参考文献17

  • 1Bosh F X,Manos M M,Munoz N etal.Prevalence of human papillomavirus in cervcal cancer:a worldwide perspective[J].J NatlCancer Inst,1995;87:796 被引量:1
  • 2Sun X L,Si L S,Cao Z S et al.Immune response to plasmid DNA encoding HPV16-L1protein[J].Chinese Medicine Journal,2000;113(3):277 被引量:1
  • 3Murakami M,Gurski K J,Steller M A.Human papillomavirus vaccines for cervicalcancer[J].Ann Med,1999;31:51 被引量:1
  • 4Donnelly J J,Mertinez D,Jansen K Uet al.Protection against papillomavirus with apolynucleotide vaccine[J].J Infectious Diseases,1996;71:314 被引量:1
  • 5Christensen N D,Kreider J W,Cladel N M et al.Monoclonal antibody-mediatedneutralization of infectious human papillomavirus type 11[J].J Virol,1990;64:5678 被引量:1
  • 6White W I,Wilson S D,Bonnez W et al.In vitro infection and type-restrictedantibody-mediated neutralization of authentic human papillomavirus type 16[J].BiomedPharmacother,1994;51:268 被引量:1
  • 7Roden R B S,Hubbert N L,Kirnbauer R et al.Papillomavirus L1 capsids agglutinatemouse erythrocytes through a proteinaceous receptor[J].J Virol,1995;69:5147 被引量:1
  • 8Vikoers C,Unckell F,Schirmacher P et al.Binding and internalization of humanpapillomavirus type 33 virus-like particles by eukaryotic cells[J].J Virol,1995;69:3258 被引量:1
  • 9Muller M,Gissmann L,Cristiano R J et al.Papillomavirus capsid binding and uptake bycells from different tissues and species[J].J Virol,1995;69:948 被引量:1
  • 10Deborah J. Armstrong, Ann Roman. The anomalous electrophoresis behavior of the hunman papillmavirus type 16 E7 protein is due to the high content of acidic amino acid residues. Biochem Biophys Res Commun, 1993,192 : 1380-1387. 被引量:1

共引文献6

同被引文献32

  • 1卢五迅,程通,李少伟,潘晖榕,沈文通,陈毅歆,张涛,郑舟,张军,夏宁邵.人乳头瘤病毒16型假病毒中和实验的建立和初步应用[J].生物工程学报,2006,22(6):990-995. 被引量:13
  • 2Walboomers JM,Jacobs MV,Manos MM,et al.Human papillomavirus is a necessary cause of invasive cervical cancer world wide.J Pathol,1999,189(1):12. 被引量:1
  • 3Bosch FX,Lorincz A,Munoz N,et al.The causal relation between human papillomavirus and cervical cancer.J Clin Pathol,2002,55(4):244. 被引量:1
  • 4Opalka D,Lachman CE,MacMullen SA,et al.Simultaneous quantitation of types antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6,11,16,and 18 by a multiplexed luminexassay.Clin Diagn Lab Immunol,2003,10(1):108. 被引量:1
  • 5Retzlaff MS,Wang F,Morley T,et al.Correlation between mouse potency and in vitro relative potency for human papillomavirus type 16 virus-like particles and Gardasil vaccine samples.Hum Vaccin,2005,1(5):191. 被引量:1
  • 6Pastrana DV,Buck CB,Pang YY,et al.Reactivity of human sera in a sensitive,high-throughput pseudovirus-based papillomavirus neutralization assay for HPV 16 and HPV 18. Virology,2004,321 (2):205. 被引量:1
  • 7Dias D, Doren JV, Schlottmann S, et al. Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papiUomaviruses 6,11, 16, and 18. Clin Diagn Lab lmrnunol,2005,12 ( 8 ) :959. 被引量:1
  • 8Ferguson M,Heath A,Johnes S,et al. Results of the first WHO international collaborative study on the standardization of the detection of antibodies to human papillomaviruses. Int J Cancer, 2006,118 (6) : 1508. 被引量:1
  • 9Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer world wide[J]. J Pathol, 1999, 189(1): 12-19. 被引量:1
  • 10Bosch FX, Lorincz A, Mufioz N, et al. The causal relation between human papillomavirus and cervical cancer[J]. J Clin Pathol, 2002, 55(4): 244-265. 被引量:1

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部